These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15871360)

  • 41. [Prevention of diabetic retinopathy in type 2 diabetic patients].
    Shiba T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():167-72. PubMed ID: 12430224
    [No Abstract]   [Full Text] [Related]  

  • 42. Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR.
    Grauslund J; Frydkjaer-Olsen U; Peto T; Fernández-Carneado J; Ponsati B; Hernández C; Cunha-Vaz J; Simó R;
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2257-2262. PubMed ID: 31112610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.
    Simó R; Hernández C; Porta M; Bandello F; Grauslund J; Harding SP; Aldington SJ; Egan C; Frydkjaer-Olsen U; García-Arumí J; Gibson J; Lang GE; Lattanzio R; Massin P; Midena E; Ponsati B; Ribeiro L; Scanlon P; Lobo C; Costa MÂ; Cunha-Vaz J;
    Diabetes; 2019 Feb; 68(2):457-463. PubMed ID: 30389750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy.
    Sha W; Wen S; Chen L; Xu B; Lei T; Zhou L
    J Diabetes Res; 2020; 2020():8867875. PubMed ID: 33274239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experience with topical brimonidine in the treatment of glaucomas].
    Maroteaux I
    J Fr Ophtalmol; 2001 Sep; 24(7):748-9. PubMed ID: 11680422
    [No Abstract]   [Full Text] [Related]  

  • 46. Relation between increased anaerobic glycolysis and visual acuity in long-standing type 2 diabetes mellitus without retinopathy.
    Mondal LK; Baidya KP; Bhattacharya B; Giri A; Bhaduri G
    Indian J Ophthalmol; 2006 Mar; 54(1):43-4. PubMed ID: 16531671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The action of calcium dobesilate in diabetic retinopathy].
    Sevin R; Cuendet JF
    Bull Mem Soc Fr Ophtalmol; 1969; 82():170-80. PubMed ID: 5402400
    [No Abstract]   [Full Text] [Related]  

  • 48. Capillary microaneurisms and shunt vessels in diabetic retinopathy. A hypothesis on pathogenesis and prevention.
    Kornzweig AL
    Isr J Med Sci; 1972; 8(8):1316-22. PubMed ID: 4647780
    [No Abstract]   [Full Text] [Related]  

  • 49. Medical treatment of diabetic retinopathy.
    Donaldson M; Dodson PM
    Eye (Lond); 2003 Jul; 17(5):550-62. PubMed ID: 12855958
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experience with Cosaldon in the treatment of circulatory disorders in the ophthalmological practice].
    Stark H
    Klin Monbl Augenheilkd; 1969 Jul; 155(1):104-9. PubMed ID: 5355393
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of darkness on inner retinal hypoxia in diabetes.
    Drasdo N; Chiti Z; Owens DR; North RV
    Lancet; 2002 Jun; 359(9325):2251-3. PubMed ID: 12103292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BG level and body weight at initial hospital visit correlate well with subsequent development of diabetic retinopathy.
    Ishihara M; Yukimura Y; Yamada T; Ohto K; Yoshizawa K
    Diabetes Care; 1986; 9(1):104-6. PubMed ID: 3948643
    [No Abstract]   [Full Text] [Related]  

  • 53. [Early initiation recommended: calcium dobesilate in diabetic retinopathy].
    Ophthalmologe; 1998 Jun; 95(6 Suppl):1-4. PubMed ID: 9702079
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diabetic retinal micro-angiopathy].
    RODRIGUEZ BARRIOS R
    Dia Med; 1962 Oct; 34():2042-5. PubMed ID: 13990869
    [No Abstract]   [Full Text] [Related]  

  • 55. A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model.
    Maciulaitiene R; Kalesnykas G; Pauza DH; Januleviciene I
    PLoS One; 2024; 19(8):e0308671. PubMed ID: 39116180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent Advancements in the Medical Treatment of Diabetic Retinal Disease.
    Szymanska M; Mahmood D; Yap TE; Cordeiro MF
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of brimonidine in the treatment of clinically significant macular edema with ischemic changes in diabetic maculopathy.
    Gupta PC; Sood S; Narang S; Ichhpujani P
    Int Ophthalmol; 2014 Aug; 34(4):787-92. PubMed ID: 24214140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy of topical administration of brimonidine to reduce ischaemia in the very early stage of diabetic retinopathy in good controlled type-2 diabetes mellitus.
    Mondal LK; Baidya KP; Bhattacharya B; Chatterjee PR; Bhaduri G
    J Indian Med Assoc; 2004 Dec; 102(12):724-5, 729. PubMed ID: 15871360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.